Adam koppel bain life sciences
WebBain Capital Life Sciences Investors is an investment fund managing more than $835 million ran by Adam Koppel. There are currently 32 companies in Mr. Koppel’s portfolio. … WebJul 14, 2024 · Dr. Adam Koppel serves as Partner, Life Sciences at Bain Capital. He serves as Managing Director at Bain Capital Life Sciences. ... Bain Capital Life Sciences: Investor: Managing Director: Boston, MA: Corporate Venture Capital: 0000-00-00: To view Adam Koppel Ph.D’s complete positions history, request access » Want detailed data …
Adam koppel bain life sciences
Did you know?
WebAug 16, 2024 · Bain expects to place investments of $25 million to $100 million in size over the next four years with various life sciences companies. “It’s a great time to be … WebAdam M. Koppel rejoined Bain Capital in 2016 as Managing Director of Bain Capital Life Sciences. He initially joined Bain Capital Public Equity in 2003 where he worked as a …
WebAdam Koppel Partner, Bain Capital Life Sciences Wellesley Hills, Massachusetts, United States 6K followers 500+ connections Join to view profile Bain Capital Harvard … WebAdam M Koppel is Managing Director at Bain Capital Life Sciences LP. See Adam M Koppel's compensation, career history, education, & memberships.
WebAdam M. Koppel rejoined Bain Capital in 2016 as Managing Director of Bain Capital Life Sciences. He initially joined Bain Capital Public Equity in 2003 where he worked as a leader within the healthcare sector until 2014. From 2014 to 2016, Dr. Koppel was EVP of Corporate Development and Chief Strategy Officer at Biogen. WebJul 12, 2024 · Areteia Therapeutics, a new biotech startup created by Population Health Partners and Knopp Biosciences, launched on Tuesday with $350 million in venture capital funding. The Series A round was led by Bain Capital Life Sciences, which has invested heavily in life sciences and raised $2 billion in new funds last year.
WebNov 17, 2024 · Adam M. Koppel rejoined Bain Capital in 2016 as Managing Director of Bain Capital Life Sciences. He initially joined Bain Capital Public Equity in 2003 where …
WebAdam M. Koppel rejoined Bain Capital in 2016 as a Partner of Bain Capital Life Sciences. He initially joined Bain Capital in 2003 as a member of the Public Equity team where he … bauplan 24 gmbhWebAdam Koppel, MD, PhD. Adam Koppel rejoined Bain Capital in 2016 as Managing Director of the Bain Capital Life Sciences Fund. He had initially joined Bain Capital Public Equity in 2003 where he was a leader. within the healthcare sector until mid-2014. During the period mid-2014 to mid-2016, Dr. Koppel was at Biogen where he served as EVP of ... tina domeijWebAug 17, 2024 · "The broad portfolio we are investing behind consists of several clinical candidates with unique chemistry to enable specific receptor targeting, which has the potential to drive a differentiated clinical profile,” said Adam Koppel, managing director at Bain Capital Life Sciences in a statement. tinadozinaWebJul 12, 2024 · During this time, Bain Capital has developed global reach, deep expertise, and a proven track record in the life sciences industries across private equity, public equity, credit, venture... tinadori slWebAdam Koppel, M.D., Ph.D. Managing Director of Bain Capital Life Sciences. Dr. Koppel is currently a member of the board of directors for Solid Biosciences. Adam M. Koppel … bauplan 21WebOct 27, 2024 · Adam Koppel, managing director of Bain Capital Life Sciences, and Nicholas Downing, a principal at the same fund, will both join the board. tina dornikWebFeb 25, 2024 · Garthwaite also co-teaches a biopharma course with Adam Koppel, managing director of Bain Capital Life Sciences. “It’s not often that you get to learn from the managing director of Bain Capital Life Sciences and one of the founders of Oak Street Health,” says Tarah Patz, a full time MBA student who is pivoting from M&A consulting to … tina dodson